1-6 of 6
Vlatko Pejsa
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Bcl-2 Family (Bcl-2, Mcl-1, Bim and Bax) and Btk Expression in B-Cell Chronic Lymphocytic Leukemia (B-CLL) Lymphocytes in Different Lymphoid Compartments and Changes during Btk Inhibitor Therapies (ibrutinib or acalabrutinib)

Ozren Jaksic, Marija Ivic, Branimir Gizdic, Zdravko Mitrovic, Ena Soric, Ozana Jaksic, Anamarija Vrkljan Vuk, Mario Pirsic, Vlatko Pejsa, Branimir Jaksic, Rajko Kusec
Journal: Blood
Blood (2022) 140 (Supplement 1): 7002–7003.
https://doi.org/10.1182/blood-2022-169649
Published: 2022
Journal Articles

Prognostic Value of TTM with TTM Distribution and Ball Score in Relapsed/Refractory Ibrutinib Treated B-CLL - in the Real-World Setting

Ozren Jaksic, MDPhD, Marija Ivic, MD, Rajko Kusec, MD PhD, Zdravko Mitrovic, MD PhD, Mario Pirsic, MD, Branimir Jaksic, MD PhD, David Cicic, MD, Vlatko Pejsa, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 14–15.
https://doi.org/10.1182/blood-2020-143030
Published: 2020
Journal Articles

Delays in Time to Deterioration of Health-Related Quality of Life Were Observed in Patients with Acute Myeloid Leukemia Receiving Venetoclax in Combination with Azacitidine or in Combination with Low-Dose Cytarabine

Keith W. Pratz, MD, Panayiotis Panayiotidis, MD, Christian Recher, MD PhD, Xudong Wei, PhD, Brian A Jonas, MD PhD, Pau Montesinos, MD PhD, Vladimir Ivanov, Andre C. Schuh, Courtney D. Dinardo, MDMSc, Jan Novak, Vlatko Pejsa, MD PhD, Don A. Stevens, MD, Su-Peng Yeh, MD, Inho Kim, MD PhD, Mehmet Turgut, MD, Nicola Fracchiolla, Kazuhito Yamamoto, MD PhD, Yishai Ofran, MD, Andrew H Wei, MBBS, PhD, Cat Bui, Katy Benjamin, Rajesh Kamalakar, MS, Jalaja Potluri, MD, Wellington Mendes, Jacob Devine, Walter Fiedler, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 33–35.
https://doi.org/10.1182/blood-2020-133912
Published: 2020
Journal Articles

Different Pattern of Expression of CD52, CD20 and CXCR-4 in Peripheral Blood, Bone Marrow and Lymph Nodes in B-Cell Chronic Lymphocytic Leukemia (B-CLL),

Ozren Jaksic, MD, PhD, Branimir Gizdic, Tajana Stoos Veic, MD, Vlatka Pandzic Jaksic, MD, PhD, Rajko Kusec, MD, PhD, Vlatko Pejsa, MD, PhD, Branimir Jaksic, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 3877.
https://doi.org/10.1182/blood.V118.21.3877.3877
Published: 2011
Journal Articles

Different Pattern of CD154 and CD40 Expression On B-CLL and T Lymphocytes In Peripheral Blood, Bone Marrow and Lymph Node Microenvironment In B-Cell Chronic Lymphocytic Leukemia (B-CLL)

Ozren Jaksic, MD, PhD, Branimir Gizdic, Tajana Stoos Veic, MD, Vlatka Pandzic Jaksic, MD, PhD, Rajko Kusec, MD, PhD, Vlatko Pejsa, MD, PhD, Branimir Jaksic, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 3607.
https://doi.org/10.1182/blood.V116.21.3607.3607
Published: 2010
Journal Articles

CD38 on B-cell chronic lymphocytic leukemia cells has higher expression in lymph nodes than in peripheral blood or bone marrow

Ozren Jaksic, Mirjana Mariana Kardum Paro, Ika Kardum Skelin, Rajko Kusec, Vlatko Pejsa, Branimir Jaksic
Journal: Blood
Blood (2004) 103 (5): 1968–1969.
https://doi.org/10.1182/blood-2003-11-3890
Published: 2004